HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice.

Abstract
Neoplastic transformation is driven by oncogenic lesions that facilitate unrestrained cell expansion and resistance to antiproliferative signals. These oncogenic DNA lesions, acquired through errors in DNA replication, gene recombination, or extrinsically imposed damage, are thought to activate multiple tumor suppressive pathways, particularly apoptotic cell death. DNA damage induces apoptosis through well-described p53-mediated induction of PUMA and NOXA. However, loss of both these mediators (even together with defects in p53-mediated induction of cell cycle arrest and cell senescence) does not recapitulate the tumor susceptibility observed in p53(-/-) mice. Thus, potentially oncogenic DNA lesions are likely to also trigger apoptosis through additional, p53-independent processes. We found that loss of the BH3-only protein BIM accelerated lymphoma development in p53-deficient mice. This process was negated by concomitant loss of RAG1/2-mediated antigen receptor gene rearrangement. This demonstrates that BIM is critical for the induction of apoptosis caused by potentially oncogenic DNA lesions elicited by RAG1/2-induced gene rearrangement. Furthermore, this highlights the role of a BIM-mediated tumor suppressor pathway that acts in parallel to the p53 pathway and remains active even in the absence of wild-type p53 function, suggesting this may be exploited in the treatment of p53-deficient cancers.
AuthorsAlex R D Delbridge, Swee Heng Milon Pang, Cassandra J Vandenberg, Stephanie Grabow, Brandon J Aubrey, Lin Tai, Marco J Herold, Andreas Strasser
JournalThe Journal of experimental medicine (J Exp Med) Vol. 213 Issue 10 Pg. 2039-48 (09 19 2016) ISSN: 1540-9538 [Electronic] United States
PMID27621418 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 Delbridge et al.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Bcl-2-Like Protein 11
  • Bmf protein, mouse
  • DNA-Binding Proteins
  • Homeodomain Proteins
  • Rag2 protein, mouse
  • Recombinases
  • Tumor Suppressor Protein p53
  • RAG-1 protein
Topics
  • Adaptor Proteins, Signal Transducing (metabolism)
  • Animals
  • Apoptosis
  • Bcl-2-Like Protein 11 (metabolism)
  • Carcinogenesis (pathology)
  • DNA Damage
  • DNA-Binding Proteins (metabolism)
  • Heterozygote
  • Homeodomain Proteins (metabolism)
  • Lymphoma (pathology)
  • Mice, Inbred C57BL
  • Recombinases (metabolism)
  • Stem Cells (metabolism)
  • Tumor Suppressor Protein p53 (deficiency, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: